Your browser doesn't support javascript.
loading
Brentuximab Vedotin plus Chemotherapy in North American Subjects with Newly Diagnosed Stage III or IV Hodgkin Lymphoma.
Ramchandren, Radhakrishnan; Advani, Ranjana H; Ansell, Stephen M; Bartlett, Nancy L; Chen, Robert; Connors, Joseph M; Feldman, Tatyana; Forero-Torres, Andres; Friedberg, Jonathan W; Gopal, Ajay K; Gordon, Leo I; Kuruvilla, John; Savage, Kerry J; Younes, Anas; Engley, Gerald; Manley, Thomas J; Fenton, Keenan; Straus, David J.
Afiliación
  • Ramchandren R; Department of Hematology/Oncology, Barbara Ann Karmanos Cancer Center, Detroit, Michigan. RRamchandren@utmck.edu.
  • Advani RH; Department of Medicine, Stanford University, Palo Alto, California.
  • Ansell SM; Division of Hematology, Mayo Clinic, Rochester, Minnesota.
  • Bartlett NL; Division of Oncology, Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri.
  • Chen R; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, California.
  • Connors JM; University of British Columbia and the Department of Medical Oncology, British Columbia Cancer Centre for Lymphoid Cancer, Vancouver, British Columbia, Canada.
  • Feldman T; John Theurer Cancer Centre, Hackensack University Medical Center, Hackensack, New Jersey.
  • Forero-Torres A; Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama.
  • Friedberg JW; James P Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, New York.
  • Gopal AK; Fred Hutchinson Cancer Research Center, University of Washington, Seattle, Washington.
  • Gordon LI; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois.
  • Kuruvilla J; Division of Medical Oncology and Hematology, Princess Margaret Hospital, Toronto, Ontario, Canada.
  • Savage KJ; University of British Columbia and the Department of Medical Oncology, British Columbia Cancer Centre for Lymphoid Cancer, Vancouver, British Columbia, Canada.
  • Younes A; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Engley G; Seattle Genetics, Inc., Bothell, Washington.
  • Manley TJ; Seattle Genetics, Inc., Bothell, Washington.
  • Fenton K; Seattle Genetics, Inc., Bothell, Washington.
  • Straus DJ; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Clin Cancer Res ; 25(6): 1718-1726, 2019 03 15.
Article en En | MEDLINE | ID: mdl-30617130
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad de Hodgkin / Protocolos de Quimioterapia Combinada Antineoplásica / Brentuximab Vedotina Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: America do norte Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad de Hodgkin / Protocolos de Quimioterapia Combinada Antineoplásica / Brentuximab Vedotina Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: America do norte Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article Pais de publicación: Estados Unidos